Literature DB >> 1751378

Lewis antigen expression in benign and malignant tissues from RBC Le(a-b-) cancer patients.

N C Langkilde1, H Wolf, T F Orntoft.   

Abstract

Eight red blood cell (RBC) Le(a-b-) individuals were selected from a series of patients with bladder or colon cancer. Defined by the presence or absence of alpha 1-4-L-fucosyltransferase activity in saliva, four of these patients were characterized as non-genuine Lewis negative [RBC Le(a-b-) with alpha 1-4-L-fucosyltransferase activity in saliva], and four as genuine Lewis negative [RBC Le(a-b-) with no alpha 1-4-L-fucosyltransferase activity in saliva]. Stainings of paraffin embedded formalin fixed tissue sections for Lea and Leb antigens were performed by means of an indirect immunohistochemical method on all malignant and benign tissue previously removed from these eight patients. Leb antigens were always expressed independently of both the Lewis and the secretor status of the individual. Lea antigens, on the other hand, showed a different staining pattern. Although primarily expressed in non-genuine Le(a-b-) individuals, Lea antigens were expressed in genuine Le(a-b-) individuals as well--to a limited extent, but still detectable. Thus, these findings seem to show that the Lewis antigen expression is tissue dependent, and it is not possible to predict tissue Lewis antigen expression by merely examining erythrocytes or saliva.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751378     DOI: 10.1111/j.1365-2141.1991.tb08061.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression.

Authors:  J Sun; J Thurin; H S Cooper; P Wang; M Mackiewicz; Z Steplewski; M Blaszczyk-Thurin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

2.  A two-site lectinoenzymatic assay for determination of tumour marker glycoproteins in rectal secretions.

Authors:  T F Orntoft; J Jepsen; P V Hansen; U Raundahl; N C Langkilde
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

Review 3.  Circulating blood group related carbohydrate antigens as tumour markers.

Authors:  T F Orntoft; E Bech
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

4.  Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers.

Authors:  Kyoko Takehara; Kaneyuki Kubushiro; Kazushige Kiguchi; Isamu Ishiwata; Katsumi Tsukazaki; Shiro Nozawa; Masao Iwamori
Journal:  Jpn J Cancer Res       Date:  2002-10

5.  Aberrant alpha 1-->2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors.

Authors:  S Yazawa; J Nakamura; T Asao; Y Nagamachi; M Sagi; K L Matta; T Tachikawa; M Akamatsu
Journal:  Jpn J Cancer Res       Date:  1993-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.